| Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors IK Mellinghoff, MY Wang, I Vivanco, DA Haas-Kogan, S Zhu, EQ Dia, ... New England Journal of Medicine 353 (19), 2012-2024, 2005 | 1738 | 2005 |
| Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma AT Parsa, JS Waldron, A Panner, CA Crane, IF Parney, JJ Barry, ... Nature medicine 13 (1), 84-88, 2007 | 1530 | 2007 |
| Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma R Beroukhim, G Getz, L Nghiemphu, J Barretina, T Hsueh, D Linhart, ... Proceedings of the National Academy of Sciences 104 (50), 20007-20012, 2007 | 1251 | 2007 |
| High-throughput oncogene mutation profiling in human cancer RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ... Nature genetics 39 (3), 347-351, 2007 | 1172 | 2007 |
| Gene expression profiling of gliomas strongly predicts survival WA Freije, FE Castro-Vargas, Z Fang, S Horvath, T Cloughesy, LM Liau, ... Cancer research 64 (18), 6503-6510, 2004 | 887 | 2004 |
| Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target S Horvath, B Zhang, M Carlson, KV Lu, S Zhu, RM Felciano, MF Laurance, ... Proceedings of the National Academy of Sciences 103 (46), 17402-17407, 2006 | 761 | 2006 |
| Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity KM Turner, V Deshpande, D Beyter, T Koga, J Rusert, C Lee, B Li, ... Nature 543 (7643), 122-125, 2017 | 696 | 2017 |
| Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma TF Cloughesy, K Yoshimoto, P Nghiemphu, K Brown, J Dang, S Zhu, ... PLoS medicine 5 (1), e8, 2008 | 677 | 2008 |
| Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment LM Liau, RM Prins, SM Kiertscher, SK Odesa, TJ Kremen, AJ Giovannone, ... Clinical Cancer Research 11 (15), 5515-5525, 2005 | 637 | 2005 |
| Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA DA Nathanson, B Gini, J Mottahedeh, K Visnyei, T Koga, G Gomez, ... Science 343 (6166), 72-76, 2014 | 629 | 2014 |
| LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin DB Shackelford, E Abt, L Gerken, DS Vasquez, A Seki, M Leblanc, L Wei, ... Cancer cell 23 (2), 143-158, 2013 | 621 | 2013 |
| Glioblastoma: from molecular pathology to targeted treatment TF Cloughesy, WK Cavenee, PS Mischel Annual review of pathology: mechanisms of disease 9 (1), 1-25, 2014 | 616 | 2014 |
| Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo G Choe, S Horvath, TF Cloughesy, K Crosby, D Seligson, A Palotie, ... Cancer research 63 (11), 2742-2746, 2003 | 577 | 2003 |
| Metabolic state of glioma stem cells and nontumorigenic cells E Vlashi, C Lagadec, L Vergnes, T Matsutani, K Masui, M Poulou, ... Proceedings of the National Academy of Sciences 108 (38), 16062-16067, 2011 | 571 | 2011 |
| Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme A Lai, A Tran, PL Nghiemphu, WB Pope, OE Solis, M Selch, E Filka, ... Journal of clinical oncology 29 (2), 142-148, 2011 | 568 | 2011 |
| Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG W Chen, T Cloughesy, N Kamdar, N Satyamurthy, M Bergsneider, L Liau, ... Journal of Nuclear Medicine 46 (6), 945-952, 2005 | 555 | 2005 |
| Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin A Lai, S Kharbanda, WB Pope, A Tran, OE Solis, F Peale, WF Forrest, ... Journal of clinical oncology 29 (34), 4482-4490, 2011 | 542 | 2011 |
| Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system PS Mischel, LP Nguyen, HV Vinters Journal of Neuropathology & Experimental Neurology 54 (2), 137-153, 1995 | 542 | 1995 |
| Single-cell analysis tools for drug discovery and development JR Heath, A Ribas, PS Mischel Nature reviews Drug discovery 15 (3), 204-216, 2016 | 517 | 2016 |
| MR imaging correlates of survival in patients with high-grade gliomas WB Pope, J Sayre, A Perlina, JP Villablanca, PS Mischel, TF Cloughesy American Journal of Neuroradiology 26 (10), 2466-2474, 2005 | 493 | 2005 |
